GRP
TBIO

Global Retirement Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Global Retirement Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,325
Closed -$560K – 2098
2021
Q2 		$560K Buy
20,325
+625
+3% +$12.3K 0.06% 272
2021
Q1 		$325K Buy
19,700
+50
+0.3% +$1.14K 0.04% 330
2020
Q4 		$362K Sell
19,650
-475
-2% -$8.5K 0.05% 290
2020
Q3 		$274K Buy
20,125
+5,100
+34% +$78.6K 0.04% 312
2020
Q2 		$269K Buy
15,025
+300
+2% +$4.52K 0.04% 309
2020
Q1 		$147K Sell
14,725
-700
-5% -$5.73K 0.03% 375
2019
Q4 		$126K Buy
+15,425
New +$142K 0.02% 441

Global Retirement Partners's TBIO Position: Q3 2021 in Review

Global Retirement Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 20,325 shares — an estimated $560K sold.

Global Retirement Partners first reported a position in TBIO in Q4 2019 and held it in 7 quarters. The position peaked at $560K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Global Retirement Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Global Retirement Partners sold 20,325 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $560K.
  • Global Retirement Partners first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Global Retirement Partners's Translate Bio, Inc. Common Stock position peaked at $560K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Global Retirement Partners's 13F filing for Q3 2021, filed 22 Oct 2021.